News

Sep 12

The PIONeeR Project to Present Late-Breaking Results from its Phase Ib/IIa umbrella study at the ESMO Congress 2024

The Presidential Symposium "Eyes to the future" will feature the first-ever presentation of the clinical trial portion of the PIONeeR...

Sep 30, 2023

Update on the umbrella clinical trial of the PIONeeR project as of October 30, 2023

Enrollment in the biomarker study is now completed (see news from January 5, 2023) but remains open in the PIONeeR Project’s umbrella...

Jan 2, 2023

More than 450 patients enrolled in the biomarker part of the PIONeeR Project

The RHU PIONeeR Project announces the completion of a major milestone with more than 450 patients enrolled in the biomarker part of the...

Jan 1, 2022

PIONeeR : mieux comprendre, prévenir et contourner les résistances à l’immunothérapie dans le cancer

Le projet PIONeeR explore plus de 400 paramètres différents chez des patients atteints de cancers bronchiques avancés, traités par des...

Jul 21, 2021

Histopathology within PIONeeR: a portrait of Laurence BAGUR

One of the key steps in the PIOneeR protocol is biopsy processing by histopathology, which is performed at the pathology service led by...

Apr 22, 2021

The PIONeeR Project is judged to be of outstanding merit, according to its SAB members

Following the third Scientific Advisory Board Meeting, which took place virtually on March 12th, 2021, and after seeing the project’s...

Mar 2, 2021

Immuno-oncology and lung cancer highlights: episode 3 (Q4 2020)

A collection of brief summaries covering recent advances in immuno-oncology that we deem important from the perspective of The PIONeeR...

Jan 1, 2021

Innovation et Galien, Fabrice Barlesi présente Projet international de recherche PIONeeR

Projet international de recherche PIONeeR : mieux comprendre, prévenir et contourner les résistances à l’immunothérapie dans le cancer du...

Sep 21, 2020

The Pioneer Project presents a biomarker analysis for its first 100 patients at the ESMO 2020 Congre

The Pioneer Project is the first study to assess over 400 biomarkers for predictive value in advanced non-small cell lung cancers (NSCLC)...

Jun 23, 2020

When PIONeeR meets QUANTIC

Fruit of the collaboration between the National Institute for Research in Digital Science and Technology (INRIA) and the PIONeeR...

Jun 19, 2020

Highlights of the event: “MI Day Lung Cancer”

An original format of conference series: Time 1: world-class specialists and MI scientists discuss new research and innovation...